1. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer
   Mitsuo Tsukamoto et al, 2017, Oncology CrossRef
2. MicroRNAs as Biomarkers in Colorectal Cancer
   Takaaki Masuda et al, 2017, Cancers CrossRef
3. Methods and novel technology for microRNA quantification in colorectal cancer screening
   Laura Moody et al, 2017, Clin Epigenet CrossRef
4. Serum microRNA signatures and metabolomics have high diagnostic value in colorectal cancer using two novel methods
   Hai-Ning Liu et al, 2018, Cancer Sci CrossRef
5. Prognostic significance of miR-21 and PDCD4 in patients with stage II esophageal carcinoma after surgical resection
   Jiandong Zhang et al, 2018, J. Cell. Biochem. CrossRef
6. The liquid biopsy in the management of colorectal cancer patients: current applications and future scenarios
   Nicola Normanno et al, 2018, Cancer Treatment Reviews CrossRef
7. Diagnostic value of RASSF1A hypermethylation in colorectal cancer: a meta-analysis
   Haochang Hu et al, 2018, Pathology - Research and Practice CrossRef
8. Current Utility and Future Applications of ctDNA in Colorectal Cancer
   Daphne Day et al, 2019 CrossRef
9. Circulating cell-free microRNAs as clinical cancer biomarkers
   Virginie Armand-Labit et al, 2017 CrossRef
10. Liquid Chromatography-Mass Spectrometry-Based Plasma Metabolomics Study of the Effects of Moxibustion with Seed-Sized Moxa Cone on Hyperlipidemia
    Qinghua Shao et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
11. Diagnostic value of WIF1 methylation for colorectal cancer: a meta-analysis.
    Haochang Hu et al, 0 CrossRef
12. The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis
    Qiliang Peng et al, 2017, Oncotarget CrossRef
13. Diagnostic value of circulating miR-21: An update meta-analysis in various cancers and validation in endometrial cancer
    Yun Gao et al, 2016, Oncotarget CrossRef
14. AngiomiRs: MicroRNAs driving angiogenesis in cancer (Review)
    Yarely Salinas‑Vera et al, 2018, Int J Mol Med CrossRef
15. Evaluation of Tissue and Circulating miR-21 as Potential Biomarker of Response to Chemoradiotherapy in Rectal Cancer.
    Susana Ourô et al, 2020, Pharmaceuticals (Basel) CrossRef
16. Serum miR-21 and miR-210 as promising non-invasive biomarkers for the diagnosis and prognosis of colorectal cancer
    Gang Li et al, 2020, Rev Esp Enferm Dig CrossRef
17. Diagnostic role of circulating MiR-21 in colorectal cancer: a update meta-analysis
    Tong Liu et al, 2020, Annals of Medicine CrossRef
18. Potential of miR-21 to Predict Incomplete Response to Chemoradiotherapy in Rectal Adenocarcinoma
    Susana Ourô et al, 2020, Front. Oncol. CrossRef
19. miRNA as promising theragnostic biomarkers for predicting radioresistance in cancer: A systematic review and meta‐analysis
    Chiman Mohammadi et al, 2020, Critical Reviews in Oncology/Hematology CrossRef
20. Colorectal cancer screening and diagnosis: omics-based technologies for development of a non-invasive blood-based method
    María Gallardo-Gómez et al, 2021, Expert Review of Anticancer Therapy CrossRef
21. The Roadmap of Colorectal Cancer Screening.
    Enea Ferlizza et al, 2021, Cancers (Basel) CrossRef
22. Interaction of Gut Microbiome and Host microRNAs with the Occurrence of Colorectal and Breast Cancer and Their Impact on Patient Immunity
    Sumadee De Silva et al, 2021, OTT CrossRef
23. MicroRNAs for Diagnosis and Treatment of Colorectal Cancer
    Haitao Mei et al, 2021, EMIDDT CrossRef
24. Seminar: Extracellular Vesicles as Mediators of Environmental Stress in Human Disease
    Vrinda Kalia et al, 2023, Environ Health Perspect CrossRef
25. Hereditary Colorectal Cancer: Emerging Concepts in Liquid Biopsies and Molecular Diagnostics
    Des Winter et al, 2025 CrossRef